's Hot Lunchtime Reads 8/10: (TWTR) (FOMX) (BDSI) (HRTX)

August 10, 2016 11:59 AM EDT

Find out which companies are about to raise their dividend well before the news hits the Street with's Dividend Insider Elite. Sign-up for a FREE trial here.

The following is a list of notable articles to help get you through the lunch hour:
  • RBC Asks 'What's the Holdup?' on Lam Research's (LRCX) Deal with KLA-Tencor (KLAC) -> Read this!

  • Twitter (TWTR) Gains as Disney Investment Values BAMTech at $3B -> Read this!

  • FDA Approval of Heron Therapeutics' (HRTX) Sustol Removes Major Overhang - Analyst -> Read this!

  • Despite Bunavail Stuggles, BioDelivery Sciences (BDSI) Should Sell Asset to Strategic Buyer - Piper Jaffray -> Read this!

  • Foamix Pharmaceuticals (FOMX) PT Doubled to $20 at Guggenheim -> Read this!

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Special Reports

Related Entities

Piper Jaffray, Twitter, Guggenheim

Add Your Comment